|
|
||||||||
Veterans Affairs Medical Center and the Department of Pathology and Laboratory Medicine (Drs. Gearing and Mirra) and the Department of Neurology (Drs. Olson and Watts), Emory University School of Medicine, Atlanta, GA.
To investigate potential heterogeneity in progressive supranuclear palsy (PSP), we examined 13 patients with neuropathologically diagnosed PSP. The clinical diagnosis of PSP was made in eight of these individuals, whereas probable AD was the primary diagnosis in the remaining five. In addition to PSP neuropathology, seven of the 13 patients (54%) showed concomitant pathologic changes of Alzheimer's disease (AD), Parkinson's disease (PD), or both disorders. These observations indicate that AD and PD changes coexist with PSP neuropathology in a substantive proportion of patients and provide further evidence of clinical and neuropathologic heterogeneity in neurodegenerative disorders. Moreover, our results suggest that PSP may be underdiagnosed and deserves more prominence in the differential diagnosis of dementing illness.
Address correspondence and reprint requests to Dr. Suzanne S. Mirra, VA Medical Center (1131, 1670 Clairmont Road, Decatur, GA 30033.
Supported by the Veterans Affairs Merit Award and NIH grants AG06790 and AG10130.
Received August 2, 1993. Accepted for publication in final form November 22, 1993.
This article has been cited by other articles:
![]() |
D. S. Knopman, B. F. Boeve, and R. C. Petersen Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia Mayo Clin. Proc., October 1, 2003; 78(10): 1290 - 1308. [Abstract] [PDF] |
||||
![]() |
M D Greicius, M D Geschwind, and B L Miller Presenile dementia syndromes: an update on taxonomy and diagnosis J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Forman, M. L. Schmidt, S. Kasturi, D. P. Perl, V. M.-Y. Lee, and J. Q. Trojanowski Tau and {alpha}-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam Am. J. Pathol., May 1, 2002; 160(5): 1725 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Saint-Cyr, L. L. Trepanier, R. Kumar, A. M. Lozano, and A. E. Lang Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease Brain, October 1, 2000; 123(10): 2091 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Halliday, C. D. Hardman, N. J. Cordato, M. A. Hely, and J. G. L. Morris A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy Brain, April 1, 2000; 123(4): 724 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Soliveri, D. Monza, D. Paridi, D. Radice, M. Grisoli, D. Testa, M. Savoiardo, and F. Girotti Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy Neurology, August 1, 1999; 53(3): 502 - 502. [Abstract] [Full Text] |
||||
![]() |
R. Oliva, E. Tolosa, M. Ezquerra, J. L. Molinuevo, F. Valldeoriola, J. Burguera, M. Calopa, M. Villa, and F. Ballesta Significant Changes in the Tau A0 and A3 Alleles in Progressive Supranuclear Palsy and Improved Genotyping by Silver Detection Arch Neurol, August 1, 1998; 55(8): 1122 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Galasko, L. Chang, R. Motter, C. M. Clark, J. Kaye, D. Knopman, R. Thomas, D. Kholodenko, D. Schenk, I. Lieberburg, et al. High Cerebrospinal Fluid Tau and Low Amyloid {beta}42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype Arch Neurol, July 1, 1998; 55(7): 937 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Friedman and M. J. Ma Case 26-1997- A 64-Year-Old Man with Progressive Dementia, Seizures, and Unstable Gait N. Engl. J. Med., August 21, 1997; 337(8): 549 - 556. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |